A detailed history of Susquehanna International Group, LLP transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 13,987 shares of ANIP stock, worth $791,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,987
Previous 25,331 44.78%
Holding current value
$791,384
Previous $1.61 Million 48.3%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$54.33 - $65.72 $616,319 - $745,527
-11,344 Reduced 44.78%
13,987 $834,000
Q2 2024

Aug 15, 2024

SELL
$58.53 - $68.82 $1.47 Million - $1.73 Million
-25,190 Reduced 49.86%
25,331 $1.61 Million
Q1 2024

May 07, 2024

BUY
$54.2 - $69.69 $2.1 Million - $2.7 Million
38,725 Added 328.29%
50,521 $3.49 Million
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $398,383 - $535,021
8,177 Added 225.95%
11,796 $650,000
Q3 2023

Nov 14, 2023

SELL
$50.28 - $64.61 $339,691 - $436,505
-6,756 Reduced 65.12%
3,619 $210,000
Q2 2023

Aug 11, 2023

SELL
$37.29 - $53.83 $90,913 - $131,237
-2,438 Reduced 19.03%
10,375 $558,000
Q1 2023

May 16, 2023

BUY
$37.61 - $45.72 $481,896 - $585,810
12,813 New
12,813 $508,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $15,929 - $20,297
-534 Reduced 3.14%
16,465 $529,000
Q2 2022

Aug 15, 2022

SELL
$23.09 - $33.46 $315,709 - $457,498
-13,673 Reduced 44.58%
16,999 $504,000
Q1 2022

May 16, 2022

BUY
$26.91 - $47.15 $433,896 - $760,246
16,124 Added 110.83%
30,672 $862,000
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $220,075 - $299,112
8,311 Added 133.25%
14,548 $477,000
Q2 2021

Aug 11, 2021

SELL
$31.86 - $38.6 $341,794 - $414,100
-10,728 Reduced 63.24%
6,237 $219,000
Q3 2020

Nov 16, 2020

SELL
$26.38 - $33.1 $281,843 - $353,640
-10,684 Reduced 38.64%
16,965 $479,000
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $34,030 - $56,963
-1,137 Reduced 3.95%
27,649 $894,000
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $632,706 - $1.4 Million
20,847 Added 262.59%
28,786 $1.17 Million
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $1.62 Million - $2.32 Million
-29,115 Reduced 78.57%
7,939 $490,000
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $1.72 Million - $2.26 Million
26,521 Added 251.79%
37,054 $2.7 Million
Q2 2019

Aug 16, 2019

BUY
$67.77 - $82.2 $297,984 - $361,433
4,397 Added 71.66%
10,533 $866,000
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $12,130 - $14,713
179 Added 3.0%
6,136 $504,000
Q1 2019

May 15, 2019

SELL
$45.83 - $70.54 $43,813 - $67,436
-956 Reduced 13.83%
5,957 $420,000
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $88,227 - $120,950
2,143 Added 44.93%
6,913 $311,000
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $207,304 - $250,377
4,770
4,770 $250,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.